Carol Robinson

Carol Robinson is the Dr Lee’s Professor of Chemistry at the University of Oxford and is the Founder Director of Oxford’s Kavli Institute for Nanoscience Discovery. She is recognised for establishing mass spectrometry as a viable technology to study the structure and function of proteins. Carol graduated from the Royal Society of Chemistry in 1979 and completed her PhD at Cambridge University. After a career break of eight years to focus on her family, she became Professor of Mass Spectrometry at Cambridge, returning to Oxford in 2009 to take up her current position. In 2016, she co-founded OMass Therapeutics (Omass.com) with a number of postdoctoral research associates from her laboratory. Her work has attracted numerous awards including the 2022 Benjamin Franklin Medal in Chemistry, the 2022 Louis Jeantet Prize for Medicine, and most recently the 2023 ASMS John B. Fenn Award for a Distinguished Contribution in Mass Spectrometry, and election to the American Philosophical Society. Car